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Abstract
Background Aseptic loosening after total hip arthroplasty
is likely related to nicotine ingestion. However, aseptic
loosening as a direct consequence of smoking habits has
not been described with regard to proximal mega-pros-
thetic femoral replacement. The aim of the present study
was to evaluate the association between nicotine con-
sumption and aseptic loosening rates after proximal mega-
prosthetic femoral replacement.
Materials and methods A consecutive series of patients
who received mega-prosthetic replacement of the proximal
femur at our hospital between 2005 and 2015 were inclu-
ded. Their files were reviewed and evaluated for the
influence of smoking on aseptic loosening rates. All living
patients were invited to complete a functional follow-up
assessment at our clinic.
Results Twenty-six patients with 27 prostheses were
included. Five patients were active smokers, and 21
patients were non-smokers. Aseptic loosening was
observed in three patients in the smoking group, whereas
none of the non-smokers developed aseptic loosening.
Fisher’s exact test showed a relationship between nicotine
consumption and aseptic loosening of the prostheses
(p = 0.003).
Conclusions Smoking increases the likelihood of aseptic
loosening after proximal mega-prosthetic femoral
replacement.
Level of evidence Level 4 according to Oxford Centre of
Evidence-Based Medicine 2011.
Keywords Smoking  Nicotine  Complication  Femur 
Proximal  Replacement  Aseptic  Loosening
Introduction
Mega-prosthetic replacement of the proximal femur has
become a standard procedure to treat primary bone tumors,
metastases and large bone defects after orthopedic surg-
eries using a large, special type of total hip arthroplasty
(Fig. 1). The orthopedic surgeon must understand the rea-
sons for postoperative complications to avoid them and
ensure that the patient has a high-quality postoperative
outcome. Although various complications occur after the
implantation of these prostheses, aseptic loosening rates are
of particular interest because they are notably higher than
after standard total hip arthroplasty (5–27 %) [1–3]. A
large meta-analysis recently demonstrated that nicotine
consumption was associated with higher aseptic loosening
rates after standard total hip arthroplasty [4]. However,
smoking has not been established as a risk factor for aseptic
loosening after mega-prosthetic proximal femoral
replacement. Considering the aforementioned recent study
results regarding standard total hip arthroplasty, we
hypothesized that smoking habits also influence the aseptic
loosening rates of mega-prosthetic proximal femoral
replacement. Therefore, this study sought to test the cor-
relation between the aseptic loosening of these prostheses
and nicotine consumption.
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In accordance with our unpublished study protocol ‘Ni-
cotine consumption and proximal femoral replacement: a
10-year single-center analysis’, the present study was
designed as a retrospective, single-center study with a one-
time cross-sectional functional follow-up assessment for all
surviving patients. We planned to include at least 20
patients with seven different surgeons in this study. To
support our hypothesis, the patients would be segregated
into smoking and non-smoking groups, and the aseptic
loosening rates would be compared between groups.
Smokers were defined as patients who had consumed
nicotine before and after implantation of the femoral mega-
prosthesis, whereas all other patients were defined as non-
smokers. Aseptic loosening was defined based on pain
upon ambulation and radiological evidence of
periprosthetic bone resorption without signs of infection
(via culture-positive swabs or blood samples). Radiological
evidence of periprosthetic bone resorption was obtained
using standardized X-rays (antero-posterior and Lauen-
stein’s oblique lateral projection) that were independently
evaluated by a radiologist and an orthopedic surgeon. A
microbiologist analyzed intraoperatively obtained swabs
that were considered positive when the same bacteria were
present in two of five swabs or when the patient had
additional signs of bacteremia (elevated C-reactive protein
[CRP] levels or leukocytosis).
Statistical analyses
The differences in aseptic loosening rates between the
groups of smokers and non-smokers were analyzed using
Fisher’s two-tailed exact test because it is reliable for small
sample sizes. In addition, a Kaplan–Meier analysis was
used to evaluate the patient and prosthesis survival rates.
The means, standard deviations (SDs), medians and ranges
were calculated for all data. All statistics were computed
using StatSoft, Inc. (2014) STATISTICA data analysis
software (StatSoft, Inc., Tulsa, OK, USA), version 12.0.
Methodological approach
To obtain our study group, we requested information from
the controlling department of our hospital, where all
diagnoses and procedures are matched to the treated
patients and retained. All potential cases of proximal mega-
prosthetic femoral replacement between 2005 and 2015
were identified according to the International Classification
of Procedures in Medicine (ICPM) figures that were used to
code operations involving femoral replacement with spe-
cial prostheses (confer Supplementary Material). All
patient files and X-rays were reviewed, and all patients who
received special femur prostheses other than a proximal
femoral replacement were excluded. Only cases in which
the surgical procedure was comparable with that used for
these implants were included (i.e., transection of the
proximal femur in the subtrochanteric region and replace-
ment of the proximal part using an implant with a large
monopolar femoral head and a cone for intramedullary
insertion into the femur). Only those cases in which the
implants were cemented and not attached to the bone with
additional screws or plates were included.
Patient baseline characteristics
Baseline data including sex, age and preoperative data
regarding body mass index (BMI), American Society of
Anesthesiologists (ASA) physical status [5], number and
type of concomitant diseases, number and type of
Fig. 1 Proximal femur replacement
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medications, alcohol consumption and use of illicit drugs
were documented based on the available patient files. The
surgical protocols were reviewed, and the data regarding
the implant manufacturer, operating surgeon, cementation,
implants at the surgical site prior to implantation, intra-
operative complications and duration of surgery were
recorded. The postoperative period was investigated, and
data were recorded regarding the application, type and
amount of postoperative antibiotics, duration of bed rest,
duration of days until fully weight bearing, rehabilitation
after inpatient treatment, postoperative chemotherapy or
radiation, duration of inpatient treatment and postoperative
complications.
Nicotine consumption and aseptic loosening
Next, the data regarding nicotine consumption prior to
surgery were recorded. Smoking habits (i.e., amount and
duration in cigarette pack years [py], consumption of
tobacco via cigar, pipe or snuff tobacco) prior to surgery
were documented based on patient files because the ward
nurses routinely record this information for every patient
upon admission. To determine postoperative nicotine
consumption, the patients (or their living relatives when the
patients were deceased) were contacted and interviewed
about their smoking habits after proximal femur
replacement.
All of the documentation from the patient follow-up
assessments and subsequent operations with the attendant
X-rays were then reviewed to determine how many patients
from each group developed aseptic loosening.
Functional follow-up assessment
All living patients were invited to complete a functional
follow-up assessment at our clinic. These evaluations were
performed using the harris hip score (HHS) [6], toronto
extremity salvage score (TESS) [7], musculoskeletal tumor
society score (MSTS) [8] and short form 36 (SF36) [9].
Moreover, leg length was recorded for every patient and
compared with the documentation in their files or measured
at the functional follow-up assessment.
Results
Methodological approach
A total of 225 cases of special femoral prostheses
implantation were identified. All of the patient files and
X-rays were reviewed, resulting in the exclusion of 198
patients who had not received a proximal femoral
replacement but a different femoral prosthesis or had
undergone a surgical procedure that differed from the study
protocol.
Patient baseline characteristics
Twenty-six patients who received proximal femoral
replacements were included in this study. Fourteen women
and 12 men received 27 prostheses, including one patient
who received bilateral prostheses. All protheses stems were
cemented with gentamicin-loaded polymethylmethacrylate
bone cement. The indications were metastatic bone disease
in 16 cases, malignant primary bone tumors in six cases,
bone loss after orthopedic surgery in four cases and a
benign bone tumor in one case (Table 1).
The average age at surgery was 65.9 years (SD ± 9.9,
median 66.8, range 37.6–81.7) with an average BMI of
27.4 (SD ± 5.6, median 26.0, range 16.4–41.1). The
patients had 4.4 concomitant diseases on average
(SD ± 2.1, median 5.0, range 1.0–7.0) and were prescribed
5.4 medications on average (SD ± 3.5, median 5.0, range
1.0–14.0). The average ASA score at surgery was 2.5
(SD ± 0.6, median 3.0, range 1.0–3.0).
The average duration of surgery was 228.8 min
(SD ± 59.2, median 240.0, range 108.0–341.0). Only one
of 27 surgeries produced an intraoperative complication
(femoral vein lesion). This lesion was sutured immediately
and healed without further incident. During the postoper-
ative period, the average duration of bed rest was 6.3 days
(SD ± 4.4, median 7.0, range 0.0–14.0), and the average
number of days until patients were fully weight bearing
was 27.4 (SD ± 23.8, median 16.5, range 0.0–100.0).
Twenty-three of 27 patients received postoperative antibi-
otics (18 received cefuroxime; five received cefuroxime
and clindamycin) for an average of 26 days (SD ± 33.7,
median 10.0, range 3.0–90.0). Inpatient treatment lasted
31.0 days on average (SD ± 16.5, median 27.0, range
8.0–94.0). Sixteen of 27 patients underwent postoperative
rehabilitation. The application of postoperative
chemotherapy was documented for 7 of 27 patients, and
postoperative radiation was documented for 9 of 27
patients. Three of our patients regularly consumed alcohol,
but none of these patients used illicit drugs.
Nicotine consumption and aseptic loosening
Five patients were smokers, whereas 21 patients were non-
smokers. The smokers consumed nicotine via cigarettes
prior to implantation for an average of 44.8 py (SD ± 17.7,
median 49, range 20–67). None of the patients ingested
tobacco via cigar, pipe or snuffing. After an average fol-
low-up period of 2.7 years (SD ± 2.3, median 1.7, range
0.1–7.9), the X-rays revealed signs of bone resorption in
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































One of these patients showed microbiological testing
results indicating infection with methicillin-resistant Sta-
phylococcus aureus (MRSA) and methicillin-resistant S.
epidermidis (MRSE) with leukocytosis and elevated CRP
levels. Thus, this patient was classified as having septic
loosening. This patient underwent a girdlestone procedure
with additional above-knee amputation due to concomitant
infection of the adjacent knee prosthesis.
The remaining three patients did not show bacterial
growth according to microbiological tests and did not have
signs of infection in their blood; hence, they were classified
as having aseptic loosening. Throughout the course of the
follow-up assessments of two of these patients, the proxi-
mal femoral replacement was exchanged for a similar
proximal mega-prosthesis, whereas the third patient
received a total femoral replacement. All three of these
patients were smokers, whereas none of the non-smokers
developed aseptic loosening. Fisher’s two-tailed exact test
revealed a significant relationship between nicotine con-
sumption (smoking) and aseptic loosening (p = 0.003).
Functional follow-up assessment
Ten of 26 patients were alive at the time of this study, with
eight of 27 prostheses remaining; all of these patients were
available for a functional follow-up assessment (Table 2).
No patient death (16/26) was related to the implantation of
the mega-prosthesis or to any subsequent complication.
The average age at the follow-up assessment was
69.2 years (SD ± 12.5; median 70.9; range 44.6–86.7).
The time from primary implantation to the follow-up
assessment was 4.7 years on average (SD ± 2.2; median
4.8; range 0.8–7.9). Of the 10 survivors, five had the
original implant; however, the implant was removed from
the hips of the other five patients. The average time
between implantation and removal was 45.1 months
(SD ± 32.3; median 45.5; range 12.0–82.9). Apart from
the aforementioned three cases of aseptic loosening and
one case of septic loosening, one patient underwent hip ex-
articulation because of local tumor recurrence (chon-
drosarcoma). Another patient was wheelchair-bound due to
Parkinson’s disease and multiple osteoporotic spinal frac-
tures. A Kaplan–Meier analysis revealed that the prosthesis
survival rates were generally higher than the patient sur-
vival rates (Fig. 3).
The six patients with proximal femoral replacements
who had the ability to walk had an average TESS of
72.5 % (SD ± 14.0; median 70.8; range 52.8–91.1), an
average MSTS of 68.3 % (SD ± 25.5; median 68.4; range
33.3–96.7), and an average SF36 physical component
summary score of 40.1 points (SD ± 11.2; median 42.9;
range 24.9–53.7), whereas the average SF36 mental com-





































































































































































































































































































































































































median 45.9; range 29.7–67.2). The HHS of all patients
with a functioning hip mega-prosthesis was 77.5 % on
average (SD ± 17.7; median 81.0; range 51.0–94.0). The
leg length measurement based on patient files or the
functional follow-up assessment showed an average dif-
ference of -0.3 (±0.9 SD) cm (median 0.0; range -1.5 to
1.0) between the prosthesis leg and the healthy contralat-
eral side.
Discussion
Aseptic loosening and nicotine consumption
The principal result of this study revealed that smoking is
related to aseptic loosening in the mega-prosthetic
replacement of the proximal femur. Thus, our hypothesis
was valid for the present sample.
The aseptic loosening rate observed in this study (3/27)was
comparablewith the rates published in literature ranging from
5-27 % [1–3]. No other studies have identified smoking as a
risk factor for aseptic loosening after the mega-prosthetic
replacement of the proximal femur. However, the effects of
smoking regarding the rates of aseptic loosening for other hip
implants and bone healing are controversial. Some studies
have not found a correlation between smoking and aseptic
loosening after total hip arthroplasty [10, 11], whereas other
studies have showna correlation between smoking and aseptic
loosening after total hip arthroplasty [12] as well as between
smoking and revision total hip arthroplasty [13]. The latter
observation is supported by our data.
Biochemically, several clues indicate how nicotine
slows bone healing. Nicotine, through the activation of the
cholinergic anti-inflammatory pathway, might partially and
indirectly slow bone healing by inhibiting tumor necrosis
factor-a (TNF-a) secretion [14]. TNF-a appears to be part















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































of a cascade that leads to the expression of crucial prote-
olytic enzymes (matrix metalloproteinases 9, 13 and 14),
which are necessary in fracture healing to progress from
the soft callus stage to endochondral ossification
[4, 15, 16]. Thus, the bone remains soft for a prolonged
period in their absence. Delayed bone healing after the
implantation of a proximal mega-prosthetic femoral
replacement is extremely problematic because the femur
and the implanted prosthesis must bear the patient’s full
bodyweight during normal ambulation and stair climbing.
During normal ambulation, this force can be 2.3 times the
patient’s bodyweight [17]. Presumably, this delayed bone
healing causes the unwanted prolonged motion of the
implant within the bone and hinders proper osseointegra-
tion, thereby leading to aseptic loosening, even when the
prosthesis is cemented.
In conclusion, smokers require special counseling before
and after implantation of a mega-prosthetic replacement of
the proximal femur to cease or at least reduce their
smoking habits. They must be informed about their
increased risk for aseptic loosening.
Functional follow-up assessment: patient
and prosthesis survival
The recent follow-up assessment revealed satisfactory
results for all of the patients who survived with a functional
hip prosthesis. This finding corroborates the current liter-
ature, which shows that successful functional results can be
achieved for most patients after implantation of a mega-
prosthetic replacement of the proximal femur [18, 19]. The
Kaplan–Meier analysis showed that the cumulative sur-
vival of the prostheses was generally longer than the
cumulative survival of the patients. In fact, the low patient
survival rates were because of metastatic tumor diseases,
which are the most common reasons for the implantation of
these prostheses. After 7 years, we observed that prosthesis
survival fell below patient survival. However, censoring of
patients explains this change. Time will reveal how long
the survivors will live with their prostheses and whether
this effect will remain after additional years of observation.
Limitations
One limitation of this study was clearly its small sample
size. Because we included all of our patients with these
types of prostheses over the past 10 years in this study, we
were unable to increase our sample size. Although seven
orthopedic surgeons performed this operation over the past
decade, the surgical procedure, according to the study
design, was the same for all of the patients and therefore
provided comparable results. Apart from smoking, we were
unable to identify any other factor that influenced aseptic
loosening. Therefore, matching the smokers with compa-
rable non-smokers based on sex, age, BMI, indication for
operation, duration of operation, chemotherapy, radiation
and implant at the surgical site prior to implantation would
not have changed the results. However, we concede that
matching was not possible because of the lack of appro-
priate matching partners. In addition, heterogeneous indi-
cations for implantation (malignant vs benign) and
comorbidities led to strong differences regarding the sur-
vival rates of the patients.
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